Describing randomisation: patients' and the public's preferences compared with clinicians' practice.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMC 2376175)

Published in Br J Cancer on October 07, 2002

Authors

V Jenkins1, L Leach, L Fallowfield, K Nicholls, A Newsham

Author Affiliations

1: Cancer Research (UK) Psychosocial Oncology Group, Brighton & Susssex Medical School, University of Sussex, Falmer, Sussex BN1 9QG, UK. V.Jenkins@biols.susx.ac.uk

Articles citing this

When "no" might not quite mean "no"; the importance of informed and meaningful non-consent: results from a survey of individuals refusing participation in a health-related research project. BMC Health Serv Res (2007) 1.69

The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. Br J Cancer (2010) 1.60

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract (2013) 1.48

Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ (2005) 1.21

Clinicians' attitudes towards clinical trials of cancer therapy. Br J Cancer (2011) 1.17

Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach. J Med Ethics (2007) 1.12

Patient, caregiver, health professional and researcher views and experiences of participating in research at the end of life: a critical interpretive synthesis of the literature. BMC Med Res Methodol (2012) 1.00

"Did the trial kill the intervention?" experiences from the development, implementation and evaluation of a complex intervention. BMC Med Res Methodol (2011) 0.99

The preferences of 600 patients for different descriptions of randomisation. Br J Cancer (2005) 0.79

Power of an effective clinical conversation: improving accrual onto clinical trials. J Oncol Pract (2012) 0.79

Barriers to accrue to clinical trials and possible solutions. Br J Cancer (2014) 0.75

Linguistic Strategies for Improving Informed Consent in Clinical Trials Among Low Health Literacy Patients. J Natl Cancer Inst (2016) 0.75

Articles cited by this

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA (2000) 13.68

Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med (1984) 4.94

Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. BMJ (1998) 4.79

How to do it. Get patients' consent to enter clinical trials. BMJ (1995) 3.76

What are the effects of the fifth revision of the Declaration of Helsinki? BMJ (2001) 3.17

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer (2000) 3.12

Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med (1991) 2.77

Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70

Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom. J Clin Oncol (1998) 2.34

Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer (1997) 2.08

Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med (1991) 2.01

How do doctors explain randomised clinical trials to their patients? Eur J Cancer (1999) 2.00

The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group. Br J Cancer (1992) 1.94

Can the written information to research subjects be improved?--an empirical study. J Med Ethics (1999) 1.88

Offering patients entry in clinical trials: preliminary study of the views of prospective participants. J Med Ethics (1996) 1.31

Information and communication in the context of a clinical trial. Eur J Cancer (2000) 1.24

Informed consent and patient's rights documents: a right, a rite, or a rewrite? Ethics Behav (1999) 0.90

Personality traits and early discontinuation from clinical trials in anxious patients. J Clin Psychopharmacol (1993) 0.87

Ethical study design. Lancet (2001) 0.82

Articles by these authors

(truncated to the top 100)

Information needs of cancer patients in west Scotland: cross sectional survey of patients' views. BMJ (1996) 8.23

Conserving large carnivores: dollars and fence. Ecol Lett (2013) 4.84

Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer (2001) 4.33

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer (2000) 3.12

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 2.63

Doctor-patient interactions in oncology. Soc Sci Med (1996) 2.30

Getting it taped: the 'bad news' consultation with cancer patients. Br J Hosp Med (1989) 2.06

1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96

Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. Eur J Cancer (2001) 1.92

Information preferences of patients with cancer. Lancet (1994) 1.89

Early discharge after surgery for breast cancer. Might not be applicable to most patients. BMJ (1998) 1.86

Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology (2004) 1.85

The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual Life Res (1996) 1.85

The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol (2000) 1.82

Genetic dissection of ethanol tolerance in the budding yeast Saccharomyces cerevisiae. Genetics (2006) 1.67

The behavioural neurology assessment. Can J Neurol Sci (2005) 1.62

The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. Br J Cancer (2010) 1.60

Can oncologists detect distress in their out-patients and how satisfied are they with their performance during bad news consultations? Br J Cancer (1994) 1.59

Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer (2000) 1.58

On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol (1998) 1.53

Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer (1999) 1.52

Clustering and switching on verbal fluency tests in Alzheimer's and Parkinson's disease. J Int Neuropsychol Soc (1998) 1.49

Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. Eur J Cancer (1999) 1.48

Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis (2007) 1.44

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2011) 1.44

Thrombotic thrombocytopenic purpura is associated with a high relapse rate after plasma exchange: a single-centre experience. Intern Med J (2008) 1.41

The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial. Br J Cancer (1995) 1.33

Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer (2003) 1.33

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.30

Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg (1991) 1.29

The Medical Interaction Process System (MIPS): an instrument for analysing interviews of oncologists and patients with cancer. Soc Sci Med (2000) 1.28

Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS). BJOG (2014) 1.22

Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med (1998) 1.22

Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study. BMJ (2001) 1.21

Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ (2005) 1.21

Drivers and barriers to patient participation in RCTs. Br J Cancer (2013) 1.19

Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Ann Oncol (2009) 1.18

Reasons given by patients for participating, or not, in Phase 1 cancer trials. Eur J Cancer (2011) 1.18

Helping the relatives of patients with cancer. Eur J Cancer (1995) 1.17

Clinicians' attitudes towards clinical trials of cancer therapy. Br J Cancer (2011) 1.17

The influence of audiotapes on patient participation in the cancer consultation. Eur J Cancer (1995) 1.17

Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase? Br J Cancer (2011) 1.16

Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer (2005) 1.14

Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection. J Infect Dis (1988) 1.11

Massive adrenal haemorrhage complicating adrenal neoplasm. Med J Aust (1979) 1.11

Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Ultrasound Obstet Gynecol (2012) 1.11

The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ (2001) 1.11

Integrating cancer survivors' experiences into UK cancer registries: design and development of the ePOCS system (electronic Patient-reported Outcomes from Cancer Survivors). Br J Cancer (2011) 1.11

Psychosocial interventions in cancer. BMJ (1995) 1.10

Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells. Exp Cell Res (2002) 1.10

Pulmonary metastasectomy in colorectal cancer: time for a trial. Eur J Surg Oncol (2009) 1.10

Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. Transplantation (1999) 1.08

Who supports the cancer counsellors? Nurs Times (1990) 1.07

Clinical features of Fabry's disease in Australian patients. Intern Med J (2002) 1.06

Participation of patients in decisions about treatment for cancer. BMJ (2001) 1.05

Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol (1999) 1.05

The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK. Br J Cancer (2005) 1.03

Psychological morbidity in newly referred patients with cancer. J Psychosom Res (1995) 1.02

Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial. Br J Cancer (2007) 1.02

Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer. Eur J Surg Oncol (1999) 1.01

Transient myeloid and erythroid aplasia associated with infectious hepatitis. Br Med J (1978) 1.00

A Phase 2 study of migalastat hydrochloride in females with Fabry disease: selection of population, safety and pharmacodynamic effects. Mol Genet Metab (2013) 0.99

Rhabdomyolysis and renal failure. Complications of narcotic abuse. Med J Aust (1982) 0.99

Mesangial IgA nephropathy. Am J Kidney Dis (1983) 0.98

Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta (1999) 0.98

Can we improve the professional and personal fulfillment of doctors in cancer medicine? Br J Cancer (1995) 0.98

An unmerciful end. Decisions not to resuscitate must not be left to junior doctors. BMJ (2001) 0.97

Cytomegalovirus infection in women attending a sexually transmitted disease clinic. J Infect Dis (1990) 0.96

Polymorphs infiltrate glomeruli in mesangial IgA glomerulonephritis. Kidney Int (1989) 0.95

A mathematical model of intervillous blood flow in the human placentone. Placenta (2009) 0.95

The treatment of early breast cancer in women over the age of 70. Br J Cancer (2011) 0.95

Different patterns of autobiographical memory loss in semantic dementia and medial temporal lobe amnesia: a challenge to consolidation theory. Neurocase (2001) 0.95

Controversy over mammographic screening. BMJ (1988) 0.94

Distinct patterns of microvascular endothelial cell morphology are determined by extracellular matrix composition. Endothelium (2004) 0.93

Anxiety and support in breast cancer: is this different for affluent and deprived women? A questionnaire study. Br J Cancer (2004) 0.93

Development of phenylalanine hydroxylase activity in guinea pig liver. Biochim Biophys Acta (1971) 0.92

Anxiety in women "at risk' of developing breast cancer. Br J Cancer (1996) 0.91

"Malignant" IgA nephropathy. Am J Kidney Dis (1985) 0.90

Effect of gestational nutrition on vascular integrity in the murine placenta. Placenta (2006) 0.90

16alpha-bromoepiandrosterone, a dehydroepiandrosterone (DHEA) analogue, inhibits Plasmodium falciparum and Plasmodium berghei growth. Am J Trop Med Hyg (2001) 0.90

The CARI guidelines. Assessment of kidney function in type 2 diabetes. Nephrology (Carlton) (2010) 0.90

Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol (2004) 0.90

Ethnicity and lupus nephritis: an Australian single centre study. Intern Med J (2011) 0.90

Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia. Ann Neurol (1988) 0.89

Neurology of Fabry disease. Intern Med J (2007) 0.89

Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement. Intern Med J (2008) 0.89

Lupus nephritis and pregnancy. Q J Med (1992) 0.89

Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy. Am J Kidney Dis (1997) 0.89

Establishment of a human in vitro model of the outer blood-retinal barrier. J Anat (2007) 0.89

Selective loss of chromatic sensitivity in demyelinating disease. Invest Ophthalmol Vis Sci (1984) 0.88

Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol (2004) 0.88

Sirolimus: a single center experience in combination with calcineurin inhibitors. Transplant Proc (2003) 0.88

The use of denial in an ethnically diverse British cancer population: a cross-sectional study. Br J Cancer (2005) 0.88

Effects of Helicobacter pylori on the cadherin-catenin complex. J Clin Pathol (2006) 0.87

Phenotype of the endothelium in the human term placenta. Placenta (2001) 0.86

ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer. Ann Oncol (2012) 0.85

Ethanol tolerance in the rat is learned. Science (1981) 0.85

Cyclic AMP and acidic fibroblast growth factor have opposing effects on tight and adherens junctions in microvascular endothelial cells in vitro. Microvasc Res (2001) 0.84

Patient-physician interactions during early breast-cancer treatment: results from an international online survey. Curr Med Res Opin (2008) 0.84

Developing a useful, user-friendly website for cancer patient follow-up: users' perspectives on ease of access and usefulness. Eur J Cancer Care (Engl) (2012) 0.84